Camlin Fine Sciences may test Rs 250-300: Mehraboon Irani

Mehraboon Irani of Nirmal Bang Securities told CNBC-TV18, "We are looking at speciality chemicals company. You can't 100 percent call it a pharma company but that is Camlin Fine Sciences where we have a target which people term it as ambitious but we have a target of Rs 250-300 for the stock over the next 30 months.""We are quite comfortable with everything that we have understood from the management of the company. Our report is out. I personally hold that company, family holds that company, promoters hold the company and clients hold the company," he added.